📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. (2019)

First Author: Herd CP

Attributed to: MICA: Assessing the therapeutic efficacy of 11beta-hydroxysteroid dehydrogenase type 1 inhibitor (AZD4017) in idiopathic intracranial hypertension funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/bmjopen-2018-027953

PubMed Identifier: 31315864

Publication URI: http://europepmc.org/abstract/MED/31315864

Type: Journal Article/Review

Volume: 9

Parent Publication: BMJ open

Issue: 7

ISSN: 2044-6055